Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Design and Validation of a New Assessment Tool for Lichen Planopilaris, the Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)

NCT03082560 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03082560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03082560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Design and Validation of a New Assessment Tool for Lichen Planopilaris, the Boston Grade of Activity in Lichen Planopilaris (Boston GOAL)
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Unknown status
Start date
February 10, 2017
Completion date
December 31, 2022
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frontal fibrosing alopecia, lichen plano-pilaris, lichen planopilaris, lichen planopilaris of scalp